宜明昂科-B:2025 年多项试验新进展 双抗亮眼

和讯网
May 23, 2025

【宜明昂科-B 早盘高开近 10%,截至发稿股价上涨 3.42%,现报 9.99 港元,成交额 1929.67 万港元】5 月 22 日,宜明昂科和 InstilBio,Inc.共同发布 IMM2510/AXN-2510 临床试验更新以及非小细胞肺癌临床开发战略宜明昂科预计将于 2025 年年底完成 IMM2510 联合化疗治疗一线非小细胞肺癌患者的 II 期临床试验入组,第三季度完成约 60 名...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10